These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 1648892)
1. [5-FU-leucovorin and cisplatin sequential chemotherapy with dipyridamole for non-small cell lung cancer (NSCLC). A pilot study for 5 cases]. Nakano S; Mitsugi K; Ichinose I; Kuroki M; Anzai K; Nakamura M; Niho Y Gan To Kagaku Ryoho; 1991 Jul; 18(8):1375-8. PubMed ID: 1648892 [No Abstract] [Full Text] [Related]
2. [5-fluorouracil + low-dose leucovorin and cisplatin sequential chemotherapy with dipyridamole for advanced nonresectable squamous cell carcinoma of the lung: a case report]. Sugimori H; Nakano S; Chifu Y; Mitsugi K; Kudo J; Ishida T; Niho Y Gan To Kagaku Ryoho; 1993 Feb; 20(2):287-90. PubMed ID: 8434968 [TBL] [Abstract][Full Text] [Related]
3. [Concurrent radiotherapy and chemotherapy for non-small-cell lung cancer--continuous infusion of low dose cisplatin and 5-FU]. Itoh Y; Fuwa N; Kikuchi Y; Matsumoto A; Muramoto H; Kato E; Shinoda M; Sugiura T Gan To Kagaku Ryoho; 1996 Oct; 23(12):1721-4. PubMed ID: 8886053 [No Abstract] [Full Text] [Related]
4. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide. Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L J Infus Chemother; 1996; 6(1):43-6. PubMed ID: 8748007 [TBL] [Abstract][Full Text] [Related]
5. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [TBL] [Abstract][Full Text] [Related]
6. [Pilot study of a continuous five-day intravenous infusion of cisplatin plus vindesine in advanced non-small cell lung cancer]. Mori K; Saito Y; Yokoi K; Tominaga K; Miyazawa N Gan To Kagaku Ryoho; 1989 Jul; 16(7):2465-8. PubMed ID: 2546506 [No Abstract] [Full Text] [Related]
7. [A study of combination chemotherapy using, 5-FU and CDDP in patients with advanced non-small cell lung cancer]. Egusa Y; Takahashi K; Oobayashi M; Isobe T; Yamakido M Gan To Kagaku Ryoho; 1996 Dec; 23(14):1997-2000. PubMed ID: 8978811 [No Abstract] [Full Text] [Related]
8. [Evaluation of chemotherapy in the treatment of advanced colorectal cancer--pilot study of 5-FU by biochemical modulation]. Katsumata K; Yamamoto K; Ohno M; Shibata K; Yamashita S Gan To Kagaku Ryoho; 1996 Mar; 23(4):459-64. PubMed ID: 8678498 [TBL] [Abstract][Full Text] [Related]
9. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
10. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer. Recchia F; Sica G; De Filippis S; Rea S; Frati L Anticancer Res; 1997; 17(5B):3761-5. PubMed ID: 9427776 [TBL] [Abstract][Full Text] [Related]
11. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490 [TBL] [Abstract][Full Text] [Related]
12. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil. Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966 [TBL] [Abstract][Full Text] [Related]
13. [Successful treatment of recurrent multiple lung metastasis from colon cancer with combination chemotherapy using methotrexate, 5-fluorouracil, and high-dose leucovorin: a case report]. Mitsugi K; Yasutake T; Etoh T; Ishimaru T; Ueda A; Nakano S; Niho Y Gan To Kagaku Ryoho; 1993 Dec; 20(15):2387-90. PubMed ID: 8259857 [TBL] [Abstract][Full Text] [Related]
14. [The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer]. Kamoshita N; Yokomori T; Iesato H; Ohya T; Nagaoka H; Okabe T; Kato Y; Takeyoshi I; Ohwada S; Morishita Y Gan To Kagaku Ryoho; 2000 May; 27(5):711-6. PubMed ID: 10832439 [TBL] [Abstract][Full Text] [Related]
15. [Continuous infusion high-dose leucovorin with cisplatin and 5-fluorouracil for a recurrent oropharynx carcinoma]. Nishino H; Ueyama N; Kanazawa T; Tanaka H; Ishikawa K; Miyata M; Kitamura K Gan To Kagaku Ryoho; 1997 Apr; 24(6):719-21. PubMed ID: 9126310 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy with etoposide, leucovorin, 5-fluorouracil and cisplatin for advanced esophageal squamous cell carcinoma. Ohwada S; Nakamura S; Izumi M; Kawashima Y; Ogawa T; Kobayashi I; Hosomura Y; Joshita T; Lino Y; Morishita Y Jpn J Clin Oncol; 1995 Jun; 25(3):79-85. PubMed ID: 7596052 [TBL] [Abstract][Full Text] [Related]
18. [Pilot study of sequential chemotherapy and radiation therapy using of liniac and fast neutron for limited small cell lung cancer]. Takiguchi Y; Nagao K; Miyamoto T; Takamura M; Yasukawa T; Kuriyama T Gan To Kagaku Ryoho; 1995 Jun; 22(7):957-9. PubMed ID: 7794004 [No Abstract] [Full Text] [Related]
19. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma. Schwarz LR Cancer; 1996 Aug; 78(3):566-7. PubMed ID: 8697406 [No Abstract] [Full Text] [Related]
20. High-dose leucovorin, fluorouracil and oral dipyridamole in the treatment of advanced colorectal cancer. Fountzilas G; Zisiadis A; Kosmidis P; Basdanis G; Makrantonakis P; Paspatis A; Tsavdaridis D; Tsavaris N; Aletras O; Tourkantonis A Anticancer Res; 1991; 11(2):865-8. PubMed ID: 2064344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]